Page 3 - International Osteoporosis Foundation

Medications

Review of impact of drug holidays on bone health

The impact of interruption of anti-osteoporosis treatment in patients on therapy with bisphosphonates or denosumab is reviewed in a new International Osteoporosis Foundation (IOF) working group paper 'Fracture risk following ...

Diseases, Conditions, Syndromes

Experts question automatic osteoporosis drug holidays

A new editorial published by an International Osteoporosis Foundation (IOF) Working Group urges physicians to individualize treatment decisions based on their patients' fracture risk, rather than automatically interrupting ...

Diseases, Conditions, Syndromes

New FRAX App launched by the International Osteoporosis Foundation

Osteoporosis management guidelines around the world now recommend that fracture risk assessment be part of any clinical evaluation for osteoporosis. As a result, rather than relying on bone mineral density values alone, physicians ...

page 3 from 14